Quantcast

Latest AVI BioPharma Stories

2008-08-07 09:01:05

AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that the Company will hold a conference call to report its second quarter 2008 financial results on Monday, August 11, 2008, at 9:30 a.m. Eastern time (6:30 a.m. Pacific time). Individuals interested in listening to the live conference call may do so by dialing 877.704.5378 toll free within the United States and Canada, or 913.312.1268 for international callers. Following the conference call, a recording...

2008-08-04 09:01:05

AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Dr. Leslie Hudson, CEO, will present an update on the transitioning of AVI from an antisense pioneer into an RNA-based drug discovery and development company. The corporate overview will include an update on AVI's clinical trials in Duchenne muscular dystrophy, its biodefense projects -- which include significant data from our ongoing Ebola and Marburg virus programs -- its partnership with Cook Medical...

2008-06-16 09:01:18

AVI BioPharma, Inc. (NASDAQ: AVII) today announced that its partner in its cardiovascular program, Global Therapeutics, the cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal stent. The device, the Global Therapeutics GTX Coronary Stent System, is also the platform for a breakthrough drug-eluting stent (DES) technology which utilizes AVI-5126, developed by AVI. The drug candidate is an improved version of antisense gene therapy to inhibit the...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related